Featured Stocks on Today's Edition of WallSt.net's 3-Minute

Press Show: INIX, BPAX, GLOW, LB 
NEW YORK, March 20 /PRNewswire-FirstCall/ -- WallSt.net's 3-Minute Press
Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino. 
Shows air Monday through Friday on:
http://www.wallst.net/wallst_tv/3_minute_press_show/index.php. 
WallSt.net's 3-Minute Press Show features in-depth interviews with public
company executives on their company and most recent press releases. The show
is designed to provide viewers with insight into a company's most recent press
release, and its impact on the company's growth. 


    The following executives were interviewed on today's show:
    -- Doug Spadaro, CEO of iFinix Corp.
       (Pink Sheets: INIX) (http://www.iFinix.com)
    -- Stephen M. Simes, CEO of BioSante Phamaceuticals, Inc.
       (Nasdaq: BPAX) (http://www.biosantepharma.com)
    -- Michael Brandofino, President and CEO of Glowpoint, Inc.
       (OTC Bulletin Board: GLOW) (http://www.glowpoint.com)
    -- Craig LaBarge, President and CEO of LaBarge, Inc.
       (Amex: LB) (http://www.labarge.com)
    About WallStreet Direct, Inc.


WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media
Group, Inc., owns and operates WallSt.net (http://www.wallst.net), a leading
source of up-to-the-minute business news, comprehensive financial tools and
original multimedia content for the investment community. In addition to
WallSt.net, WallStreet Direct owns and operates WallStRadio
(http://radio.wallst.net) an online hub for business podcasts from well-known
business news personalities and publishers. We have received ten thousand
seven hundred seventy dollars from BioSante Pharmaceuticals, Inc. for media
and advertising services. We have received nine hundred ninety five dollars
from Glowpoint, Inc. for media and advertising services. We have received
three thousand one hundred fifty dollars and two million five hundred thousand
restricted shares of INIX from IFinix Corporation for media and advertising
services. We have received four hundred ninety five dollars from LaBarge, Inc.
for the dissemination of this press release. To read our full disclaimer, and
for a complete list of our advertisers, and advertising relationships, visit
http://www.wallst.net/disclaimer/disclaimer.php. 
About iFinix Corp. 
iFinix is a diversified information technology services and solutions
company with expertise in systems integration, outsourcing, infrastructure and
server technology. iFinix has established a product line that delivers
financial and business information with streaming, real-time market data, news
and analytics to professionals and active individual investors. The company's
suite of products includes iFinix RealTime, iFinix Trader and eFinix. Visit
http://www.iFinix.com. 
About BioSante Pharmaceuticals, Inc. 
BioSante is developing a pipeline of products primarily for transdermal
administration of estradiol and testosterone. BioSante's lead products include
LibiGel(R) (transdermal testosterone gel) in Phase III clinical development by
BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol
Assessment) for the treatment of female sexual dysfunction (FSD), and
Elestrin(TM) (estradiol gel) developed through FDA approval by BioSante,
indicated for the treatment of moderate-to-severe vasomotor symptoms
associated with menopause, marketed in the U.S. by Nycomed US, BioSante's
licensee. Also in development are Bio-T-Gel(TM), a testosterone gel for male
hypogonadism, and an oral contraceptive in Phase II clinical development using
BioSante patented technology. The current market in the U.S. for estrogen and
testosterone products is approximately $2.5 billion and for oral
contraceptives approximately $3.0 billion. The company also is developing its
calcium phosphate nanotechnology (CaP) for novel vaccines, drug delivery and
aesthetic medicine (BioLook(TM)). Additional information is available online
at: www.biosantepharma.com. 
About Glowpoint, Inc. 
Glowpoint, Inc. is a premiere, IP-based managed video communications
services provider. Glowpoint is innovating video communications with services
supporting traditional video conferencing, Telepresence VNOC, Broadcast
Content Acquisition & Delivery, and Call Center Applications. Glowpoint's
services are delivered over a robust, video-centric network that reaches
around the world and serves clients ranging from Fortune 100 enterprises and
leading broadcast networks to SMB markets. Glowpoint is headquartered in
Hillside, New Jersey. To learn more, visit www.glowpoint.com. 
About LaBarge, Inc. 
LaBarge, Inc. is a broad-based provider of electronics to
technology-driven companies in such diverse markets as natural resources,
defense and industrial. The Company provides its customers with sophisticated
electronic and electromechanical products through contract design and
manufacturing services. Headquartered in St. Louis, LaBarge has operations in
Arkansas, Missouri, Oklahoma, Pennsylvania and Texas. The Company's Web site
may be accessed at http://www.labarge.com. 


     Contact
     WallSt.net
     800-4-WALLST




SOURCE  WallStreet Direct, Inc.; iFinix Corp.; Glowpoint, Inc.; BioSante
Pharmaceuticals, Inc.; LaBarge, Inc. 
CONTACT:
WallSt.net, 1-800-4-WALLST
-0- Mar/20/2008 11:00 GMT